TargED Biopharmaceuticals

Series-A
targedbiopharmaceuticals.com Biotech & Healthcare Utrecht, The Netherlands
Total Funding $44M
Latest Round Undisclosed Series-A
Last Announced Jul 2, 2025
Investors 11 Backers
Decision Makers 5 Available

About TargED Biopharmaceuticals

TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Utrecht, The Netherlands
Tracked Since Nov 8, 2026

Web & Domain Identity

Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised undisclosed · Series-A

    fundraisingfox.com

  2. Capital Raise

    Raised $44,000,000 · Series-A

    Backed by Andera Partners

Investors & Backers

11
Andera Partners
Lead
BioGeneration Ventures
Curie Capital
EIC Accelerator
European Innovation Council Fund
First
Fund+
Hadean Ventures
Inkef
Sunstone Life Science Ventures
Utrecht Health Seed Fund

Funding History

2 Rounds
Series-A equity · Jul 2, 2025
Series-A equity · Feb 1, 2022

Round backers: Andera Partners

Founders & Leadership

2

Kristof Vercruysse

CEO

Work email & phone locked Unlock →

Roger Franklin

Director

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts